This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Reversible posterior leukoencephalopathy syndrome (RPLS) is a newly characterized clinico-neuroradiologic syndrome.1 Symptoms of this syndrome include seizures, visual abnormalities, cortical blindness, headache, nausea, lethargy, confusion, and hypertension. Radiologically, abnormalities consistent with reversible white matter edema in the occipital and parietal lobes are characteristic. Underlying conditions that reportedly trigger RPLS include hypertensive encephalopathy, eclampsia, and immunosuppressive drug therapy for neoplasm or organ transplantation. We report a case of RPLS that occurred after blood transfusion.
Case report. A 45-year-old woman with no significant history was referred to a local gynecologist for shortness of breath and bilateral pedal edema. She had myoma uteri, abnormal vaginal bleeding, and iron deficiency anemia. Her hemoglobin was 2.0 g/dl and her hematocrit was 9.0%. Packed red blood cell infusion of 200 ml was performed four times, in addition to daily intravenous administration of saccharated ferric oxide. Her hemoglobin subsequently increased to 10.0 g/dl and her hematocrit improved to …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
